Influences of Hashimoto's Thyroiditis as Prognostic Factor of Papillary Thyroid Carcinoma.
10.3342/kjorl-hns.2014.57.5.320
- Author:
Hyun Ju PARK
1
;
Dong Kun LEE
;
Ji Won SEO
;
Myung Koo KANG
;
Heon Soo PARK
;
Rock Bum KIM
;
Sung Hwan SUH
;
Mi Kyoung PARK
;
Duk Kyu KIM
;
Jong Chul HONG
Author Information
1. Dong-A University College of Medicin, Busan, Korea.
- Publication Type:Original Article
- Keywords:
Hashimoto's thyroiditis;
Papillary thyroid carcinoma;
Prognosis
- MeSH:
Humans;
Lymph Nodes;
Medical Records;
Neoplasm Metastasis;
Prognosis;
Recurrence;
Retrospective Studies;
Thyroid Gland*;
Thyroid Neoplasms*;
Thyroiditis*
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2014;57(5):320-324
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: As a prognostic factor, the association of Hashimoto's thyroiditis (HT) with papillary thyroid carcinoma (PTC) is still controversial. The aim of this study is to compare clinicopathologic parameters between PTC alone and PTC with HT patients. SUBJECTS AND METHOD: We reviewed the medical record retrospectively. 205 patients underwent thyroid surgery from January 2006 to December 2008. Among the 205 patients, 120 patients were included in this study. We compared various clinicopathologic parameters such as gender, tumor size, multifocality, lymphovascular invasion, extrathyroidal extension, central lymph node metastasis, and lateral lymph node metastasis between PTC alone and PTC with HT patients. RESULTS: 18.3% of PTC patients were associated with HT. There were no significant differences in clinocopatholgic parameters such as gender, tumor size, multifocality, lymphovascular invasion, extrathyroidal extension, central lymph node metastasis or lateral lymph node metastasis. Tumor recurrences were found in 6 out of 98 cases of PTC alone and in 3 out of 22 cases of PTC with HT. There was no significance between two groups (p=0.363). CONCLUSION: Results indicate that HT may not be associated with clinicopathologic factors in PTC.